Pharmacological evaluation of acetyl-11-¿-keto¿-boswellic acid mediate - Yegireddy, Muralidhar;Kaliki, Adilaxmamma
39,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
20 °P sammeln
  • Broschiertes Buch

Mastitis is an important economic disease-causing production loss in the dairy industry. Antibiotics are becoming ineffective in controlling mastitis due to the emergence of resistant strains requiring the development of novel therapeutic agents. In this study, the authors present the phytochemical synthesis of silver nanoparticles (AgNPs) with acetyl-11- -keto-betaboswellic acid and evaluation of their activity in Staphylococcus aureus induced murine mastitis. Boswellic acid-mediated AgNP (BANS) were oval, polydispersed (99.8 nm) with a minimum inhibitory concentration of 0.033 µg ml-1…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Mastitis is an important economic disease-causing production loss in the dairy industry. Antibiotics are becoming ineffective in controlling mastitis due to the emergence of resistant strains requiring the development of novel therapeutic agents. In this study, the authors present the phytochemical synthesis of silver nanoparticles (AgNPs) with acetyl-11- -keto-betaboswellic acid and evaluation of their activity in Staphylococcus aureus induced murine mastitis. Boswellic acid-mediated AgNP (BANS) were oval, polydispersed (99.8 nm) with a minimum inhibitory concentration of 0.033 µg ml-1 against S. aureus, inhibitory concentration (IC50) of 30.04 µg ml-1 on mouse splenocytes and safe at an in vivo acute oral dose of 3.5 mg kg-1 in mice. Mastitis was induced in lactating mice by inoculating S. aureus (log10 5.60 cfu) and treated 6 h post-inoculation with BANS (0.12 mg kg-1, intramammary and ip), and cefepime (1 mg kg-1, ip). BANS treatment significantly (P < 0.05) reduced bacterial load, CRP, SOD, CAT activities and neutrophil infiltration in affected mammary glands. BANS could be a potential therapeutic agent for managing bovine mastitis.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr. Muralidhar Yegireddy ist Assistenzprofessor mit sechs Jahren Lehr- und Forschungserfahrung in Veterinärpharmakologie und -toxikologie auf Undergraduate- und Postgraduate-Ebene. Er ist ein erfahrener Forscher in den Bereichen Nanotechnologie, Toxikologie und Arzneipflanzen mit mehr als 10 internationalen Veröffentlichungen.